Windtree Therapeutics, Inc.
WINT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $919 | $2,786 | $5,355 | $39,724 |
| - Cash | $1,779 | $4,319 | $6,172 | $22,348 |
| + Debt | $1,822 | $16,830 | $2,280 | $17,893 |
| Enterprise Value | $962 | $15,297 | $1,463 | $35,269 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$84 | -$82 | -$1,061 | -$869 |
| % Margin | – | – | – | – |
| EBITDA | -$1,474 | -$20,159 | -$39,461 | -$76,640 |
| % Margin | – | – | – | – |
| Net Income | -$5,487 | -$20,291 | -$39,208 | -$67,636 |
| % Margin | – | – | – | – |
| EPS Diluted | -104.35 | -4,711.54 | -56,011 | -122,924 |
| % Growth | 97.8% | 91.6% | 54.4% | – |
| Operating Cash Flow | -$15,402 | -$13,437 | -$19,452 | -$23,664 |
| Capital Expenditures | -$12 | -$15 | -$13 | -$279 |
| Free Cash Flow | -$15,414 | -$13,452 | -$19,465 | -$23,943 |